Wettig Thane bought KYNB
February 3, 2026 · Form 4 insider transaction
Wettig Thane bought 60,000 shares of Kyntra Bio, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
60,000
Price
$0.00
Total value
N/A
InsiderWettig Thane
RoleOfficer, Director
CompanyKyntra Bio, Inc. (KYNB)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 3, 2026
Filing dateFebruary 5, 2026
Shares owned after60,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests in equal amount quarterly over 4 years measured from 2/3/2026.